Solvay reported Citigroup stake and Solvay stock trades at EUR 24.92

Published on 10/12/2026 at 10:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Citigroup crossed 3.09 percent on September 24, 2026. Solvay stock costs EUR 24.92 on October 12, 2026 versus the Xetra close of EUR 24.98.

Key points in brief

Solvay reported a Citigroup holding totaling 3.09 percent after a September 24, 2026 threshold crossing.
Jefferies forecast third-quarter EBITDA of EUR 175.00 million, 4.00 percent below consensus.
Solvay stock was at EUR 24.92 at Lang & Schwarz on October 12, 2026, versus the EUR 24.98 Xetra close.
The company is scheduled to report third-quarter results on November 4, 2026.

Makrofotografie von glänzenden Kristallstrukturen und chemischen Granulaten in Nahaufnahme — Makroaufnahme kristalliner Chemikalienstruktur zeigt feine Materialdetails, typisch für Solvay S.A. Produktionsgrundstoffe, BE0003470755 industriell relevant, Illustration mit AI erstellt.

Solvay (ISIN BE0003470755) was trading at EUR 24.92 at Lang & Schwarz on October 12, 2026 at 9:53 a.m. CEST. The company had reported on October 1 that Citigroup's holding had crossed the 3.00 percent threshold, reaching 3.09 percent on September 24, 2026, according to Solvay.

Citigroup stake reaches 3.09 percent

The notification listed 0.43 percent in voting rights and 2.66 percent in equivalent financial instruments. The combined position therefore stood at 3.09 percent, based on a denominator of 105,876,416 shares.

For investors, the filing changes the ownership picture but does not alter Solvay's operating outlook. The next material test remains the company's third-quarter report, where production and cash generation are central to the earnings discussion.

Jefferies sees EBITDA pressure

According to MarketScreener on September 21, 2026, Jefferies analyst Helena Xu maintained an Underperform rating and a EUR 20.00 price target. Xu forecast third-quarter 2026 EBITDA of EUR 175.00 million, 4.00 percent below analyst consensus, and full-year EBITDA of EUR 760.00 million, 2.00 percent below consensus.

The comparison matters because Solvay's 2026 underlying EBITDA outlook is EUR 770.00 million to EUR 850.00 million. Jefferies' estimate sits EUR 10.00 million below the lower end of that range, while the report also cited pressure in soda ash and uncertainty around the restart of peroxide operations in Saudi Arabia.

Results date gives the next marker

MFN lists November 4, 2026 as Solvay's third-quarter reporting date. The date gives the ownership filing a clear operating follow-up, because the market will have new evidence on whether the company can remain within its EBITDA guidance range.

Solvay's market capitalization was EUR 2.6 billion as of October 12, 2026. Its 52-week range was EUR 23.54 to EUR 29.86, placing the current Lang & Schwarz price EUR 1.38 above the low and EUR 4.94 below the high.

Solvay stock stays near yearly low

At EUR 24.92, Solvay stock was EUR 0.06, or 0.24 percent, below the Xetra close of October 9, 2026 at EUR 24.98. The price was in trading at Lang & Schwarz, while the quantified comparison with the Xetra close keeps the daily move separate from the Euronext Brussels listing.

The further course of trading is shown by the continuously updated real-time quote of Solvay stock.